Ascentia Biomedical Corp. engages in the development and commercialization of pharmaceutical and biomedical products for the treatment of asthma, arthritis, psoriasis, and cancer. Its services include toxicology, mechanism of action, efficacy in surrogate models of disease, antigenicity and immunogenicity, immunosuppression, cellular binding and identification, pharmacokinetic determination, and custom consultation. In addition, the company provides contract and preclinical research support for other bio-medical/pharmaceutical companies. Ascentia Biomedical is based in Bellevue, Washington.